Wits RHI

24/04/2026

| . Wits RHI Dr Pascalia Munyewende appointed to the Lancet Africa Climate- Working Group 2 Lead. Driving African-led research on climate and health, strengthening resilience and shaping global policy.

24/04/2026

| Cervical Cancer Prevention in Action. Wits RHI highlights the HOPE study, published in The Lancet Global Health, providing strong evidence that South Africa’s HPV vaccination programme protects girls, including those living with . This marks an important milestone in prevention and public health impact. Read more: https://bit.ly/wits-rhi-hpv

23/04/2026

Shaping the future of Mpox response. Wits RHI is contributing to the global Mpox R&D roadmap through a One Health approach, co-chairing the World Health Organization (WHO) Poxvirus Collaborative Open Research Consortium to advance diagnostics, treatments, and vaccines while strengthening pandemic preparedness.

Wits RHI is playing a key role in shaping the global Mpox R&D roadmap through a One Health approach , working with international partners as Co-Chair of the WHO Poxvirus Collaborative Open Research Consortium (CORC) to strengthen pandemic preparedness and accelerate the development of diagnostics, treatments and vaccines for future outbreaks.

Read More: https://ow.ly/5u0350YNoQq

23/04/2026

Wits RHI Rutendo Bothma, will serve as Co-Chair of the 3rd Southern African HIV Clinicians Society Long-Acting HIV Treatment and Prevention Conference on 15 September 2026 in Johannesburg. Her role reflects leadership in implementation research and advancing equitable access to HIV innovation.

Registration is open — The 3rd SAHCS Long-Acting HIV Treatment and Prevention Conference brings together a community of healthcare workers advancing the future of HIV care in Africa.

Join us on 15 September 2026 | Maslow Hotel, Sandton, Johannesburg, South Africa.

For more information and to register, visit: https://sahivsoc.org/Subheader/Index/conference---the-future-of-arvs-in-africa

CPD accredited. Take advantage of the early bird registration fee.

#

21/04/2026

Wits RHI's Executive Director, Professor Helen Rees, will be part of a global expert panel at the International Papillomavirus Society - IPVS & CHIC Special Online Event. Topic: Sustaining & Screening in Africa. 13 May 2026 | 16:00 CEST | Virtual | English + French | interpretation | CME Credits available. Register now. Register now: https://bit.ly/zoom-join-webinar

20/04/2026

Professor Helen Rees Leading Global . Wits RHI is proud to share the global leadership of Prof Rees, who is co-chairing the Poxviridae Collaborative Open Research Consortium (CORC) under the World Health Organization (WHO)’s newly launched initiative on pandemic preparedness. Through her leadership, has helped shape the first Research Roadmap a critical global framework guiding research, diagnostics, vaccines, and response strategies for future outbreaks. Global impact. Scientific leadership. Collaborative action. Find out more: https://anrs.fr/en/all-news/publication-of-the-rd-roadmap-for-pathogen-families/

17/04/2026

We’re excited to see Wits RHI, Prof Saiqa Mullick, featured at the upcoming 3rd Long-Acting Treatment and Prevention Conference. Join her on 15 September 2026 in Johannesburg as she shares insights on the future of in Africa at this important gathering hosted by the Southern African HIV Clinicians Society. Don’t miss out early bird registration is now open: https://lnkd.in/dttqRygC

We're thrilled to welcome Professor Saiqa Mullick to the 3rd Long-Acting Treatment and Prevention Conference. Join us on 15 September 2026 in Johannesburg to hear her insights on the future of HIV prevention in Africa.

Don't miss out - take advantage of our early bird offer and register today at

https://sahivsoc.org/Subheader/Index/conference---the-future-of-arvs-in-africa

Wits RHI

15/04/2026

📢Celebrating leadership. Wits RHI Prof Helen Rees has been named among the 20 Leaders Shaping Health Across Africa by Meridian Letters. As Executive Director of Wits RHI, her work continues to shape health systems through science, policy, and innovation advancing , , and across the continent. Her leadership turns evidence into real-world impact. Read more: https://bit.ly/helenrees Wits - University of the Witwatersrand Wits Faculty of Health Sciences

09/04/2026

📢Leading Global Pandemic Preparedness. Wits RHI is co-chairing the Poxvirus CORC and co-leading the global R&D Roadmap, helping accelerate diagnostics, treatments, and vaccines ahead of future outbreaks.
Read the full press release: https://bit.ly/4vkMSZg

02/04/2026

Join Wits RHI & Clinton Health Access Initiative. Dive into an interactive webinar on innovations in service delivery and facility-level implementation. Hear from early adopters about what works in getting to the people who need it most. Don’t miss this chance to learn, engage, and be inspired Register now: https://bit.ly/4sHJHcw

27/03/2026

A powerful step forward in the fight against 💙 . Wits RHI is proud to be part of the newly launched , an innovative study strengthening HIV treatment in infants by integrating broadly neutralizing antibodies (bNAbs) into early care. At , the study is led by Dr Faeezah Patel, Maternal & Child Health Senior Medical Officer and Principal Investigator, who also serves as Vice-Chair of the ENABLE Project’s Internal Exploitation & Sustainability Committee (IESC). Funded by Global Health EDCTP3 and the European Union, ENABLE brings together 21 partners across Africa, Europe, and the US to drive scientific innovation and improve early HIV treatment outcomes for infants. Read more | https://wrhi.ac.za/press-release/enableproject/

27/03/2026

This World TB Month, we spotlight impact. Wits RHI, led by Prof Lee Fairlie, is advancing the M72/AS01E vaccine trial driving a turning point in bringing us closer to a future free of 💙African-led. Impact-driven.This is progress.

Find out how a community approach to developing a new TB vaccine and learning from the past has led to the M72 vaccine